What Is Sleep Apnea?
Obstructive sleep apnea (OSA) syndrome is a sleep-related breathing disorder characterized by repetitive episodes of partial or complete upper airway obstruction during sleep. This obstruction causes breathing pauses (apneas) or significant reductions in airflow (hypopneas), leading to oxygen desaturation and microarousals.
Prevalence ranges from 9-38% in the general adult population and is more common in men, people with obesity, and older adults. In Brazil, the EPISONO study (Tufik et al., 2010) identified OSA (AHI greater than or equal to 5) in roughly 32.8% of São Paulo adults — an urban prevalence shaped by a heavy burden of risk factors (obesity, age). The vast majority of cases remain undiagnosed.
OSA is an independent risk factor for resistant arterial hypertension, coronary artery disease, cardiac arrhythmias, stroke, and cardiovascular mortality. In addition, sleep fragmentation causes excessive daytime sleepiness, cognitive impairment, and increased risk of motor vehicle accidents.
Pathophysiology
The upper airway is a collapsible tube supported by the tonic activity of the pharyngeal dilator muscles, especially the genioglossus. During sleep, there is a physiological reduction in muscle tone. In patients with OSA, anatomical and neuromuscular factors make the airway prone to collapse.
Obstruction drives respiratory effort against the closed airway, increased intrathoracic negative pressure, intermittent hypoxemia, and hypercapnia. The microarousal restores muscle tone and reopens the airway, but fragments sleep architecture. This cycle repeats dozens to hundreds of times per night.
Intermittent Hypoxemia
Repeated desaturation-reoxygenation cycles drive oxidative stress, systemic inflammation, and endothelial dysfunction — all mediators of cardiovascular risk.
Sympathetic Hyperactivation
Microarousals activate the sympathetic nervous system, raising blood pressure, heart rate, and the risk of nocturnal arrhythmias.
Sleep Fragmentation
Repeated microarousals block deep and REM sleep, causing daytime sleepiness, cognitive deficits, and metabolic disturbances.
Symptoms
OSA symptoms split into nocturnal and daytime. The bed partner often notices the loud snoring and breathing pauses first. The patient may not realize their sleep is fragmented and blames daytime symptoms on other causes.
Symptoms of Obstructive Sleep Apnea
- 01
Loud and habitual snoring
Present in more than 90% of patients. Typically loud and irregular, with pauses followed by gasps or choking sounds.
- 02
Witnessed breathing pauses
Apneas witnessed by the bed partner. The patient may wake with a feeling of suffocation or choking.
- 03
Excessive daytime sleepiness
Need to nap during the day, difficulty staying awake in meetings, while reading, or while driving.
- 04
Morning headache
Morning headache, usually frontal, caused by hypercapnia and nocturnal cerebral vasodilation.
- 05
Nocturia
Frequent nighttime urination, driven by atrial natriuretic peptide release from respiratory effort.
- 06
Cognitive impairment
Difficulty with concentration, memory, and attention. Reduced professional and academic performance.
- 07
Mood alterations
Irritability, depression, and anxiety linked to chronic sleep fragmentation and hypoxemia.
Diagnosis
Definitive diagnosis of OSA requires polysomnography (type I in the laboratory or type III at home). The main parameter is the Apnea-Hypopnea Index (AHI), which quantifies the number of obstructive events per hour of sleep.
Screening questionnaires such as the STOP-BANG help identify patients with a high probability of OSA. STOP-BANG scores greater than or equal to 5 have high sensitivity for moderate to severe OSA.
🏥Classification of OSA Severity
- 1.AHI 5-14 events/hour: mild OSA — consider treatment if symptomatic
- 2.AHI 15-29 events/hour: moderate OSA — treatment indicated
- 3.AHI greater than or equal to 30 events/hour: severe OSA — mandatory treatment
- 4.Minimum saturation below 80%: an additional severity marker that signals elevated cardiovascular risk
- 5.Elevated microarousal index: correlates with daytime sleepiness and cognitive impairment
POLYSOMNOGRAPHY: LABORATORY VS. HOME
| FEATURE | LABORATORY PSG (TYPE I) | HOME PSG (TYPE III) |
|---|---|---|
| Channels monitored | EEG, EOG, EMG, ECG, airflow, effort, SpO2, position | Airflow, effort, SpO2, position |
| Sleep staging | Yes — identifies stages N1-N3 and REM | No — does not differentiate wake from sleep |
| Detection of other disorders | Periodic limb movements, parasomnias | Does not assess |
| Convenience | Requires a night in the laboratory | Comfort of home |
| Main indication | Suspicion of other sleep disorders | OSA screening in high clinical probability |
Differential Diagnosis
Excessive daytime sleepiness, snoring, and morning fatigue have several causes beyond OSA. The sleep medicine specialist or pulmonologist sorts out hypersomnolence, OSA, narcolepsy, and other sleep disorders using polysomnography; the medical acupuncturist works in coordination with this team as part of multidisciplinary care.
DIFFERENTIAL DIAGNOSIS
Differential Diagnosis
Obesity Hypoventilation Syndrome
- BMI greater than 30 + daytime hypercapnia (PaCO2 greater than 45 mmHg)
- Hypoxemia even while awake
- Polycythemia and cor pulmonale in advanced cases
- Frequently coexists with OSA
- Elevated daytime PaCO2 indicates ventilatory failure
- Requires BiPAP or AVAPS, not CPAP alone
Diagnostic Tests
- Daytime arterial blood gas
- Spirometry
- Polysomnography with BiPAP titration
- Echocardiogram (cor pulmonale)
In this syndrome, noninvasive mechanical ventilation is the priority. Acupuncture can support the weight-loss program as an adjunct to the main treatment.
Central Apnea (vs Obstructive)
- Breathing pauses without thoracic effort (central) vs with effort (obstructive)
- Cheyne-Stokes apnea: crescendo-decrescendo airflow pattern
- Frequently associated with CHF, stroke, or opioid use
- Predominantly central AHI on polysomnography
- New-onset central apnea in a patient on CPAP: complex central apnea syndrome
Diagnostic Tests
- Laboratory polysomnography (distinguishes central from obstructive)
- Echocardiogram (CHF as cause)
- BNP if CHF is suspected
Central apnea requires treating the underlying cause (CHF, opioids, stroke). The medical acupuncturist can contribute to CHF management and post-stroke rehabilitation as part of multidisciplinary care.
Insomnia
- Difficulty falling or staying asleep, without prominent snoring
- Daytime tiredness but not classic sleepiness (subtle distinction)
- Polysomnography: prolonged sleep latency, reduced efficiency, no apneas
- Frequently comorbid with OSA (insomnia-OSA complex)
- Resistant insomnia: investigate underdiagnosed OSA as a cause of fragmentation
Diagnostic Tests
- Polysomnography
- Sleep diary for 2 weeks
- Actigraphy
Medical acupuncture has evidence for relieving insomnia symptoms and can be integrated into the care plan when polysomnography rules out significant OSA, alongside sleep hygiene and CBT-I when indicated.
Narcolepsy
- Irresistible daytime sleepiness since childhood or adolescence
- Cataplexy: sudden loss of muscle tone with strong emotion (pathognomonic)
- Sleep paralysis and hypnagogic hallucinations
- Polysomnography + MSLT: REM sleep latency less than 15 min in 2 or more naps
- Severe cataplexy with falls: trauma risk
Diagnostic Tests
- Polysomnography + multiple sleep latency test (MSLT)
- HLA DQB1*06:02 (genetic marker)
- CSF hypocretin-1 (type 1)
Narcolepsy requires specific pharmacological treatment. As an adjunct, acupuncture can help manage fatigue and improve sleep quality.
Hypothyroidism with Snoring
- Late-onset snoring in an adult with no prior complaints
- Fatigue, weight gain, hoarse voice, dry skin
- Macroglossia and mucopolysaccharide deposition in the airways
- Elevated TSH with reduced free T4
- Severe hypothyroidism can cause OSA that resolves completely with levothyroxine
Diagnostic Tests
- TSH and free T4
- Polysomnography before and after hypothyroidism treatment
- Anti-TPO antibodies (Hashimoto)
The medical acupuncturist screens for hypothyroidism in every patient with late-onset snoring. Normalizing TSH with levothyroxine may eliminate the need for CPAP.
Obstructive versus Central Apnea
Obstructive sleep apnea (OSA) and central sleep apnea (CSA) share the same clinical picture — breathing pauses during sleep — but differ fundamentally in mechanism and treatment. In OSA, respiratory effort persists (thoracic and abdominal movements are detected during the apnea), but airflow is absent because the upper airway is mechanically obstructed. In CSA, both effort and airflow are absent — central respiratory drive is temporarily inhibited and no command reaches the respiratory muscles. Polysomnography with respiratory effort channels (thoracic and abdominal bands) is the test that tells them apart. Cheyne-Stokes apnea, a crescendo-decrescendo pattern of tidal volume with interspersed central apneas, strongly suggests congestive heart failure as the cause.
CSA treatment targets the underlying cause: optimize CHF with carvedilol, ACE inhibitors, and diuretics; reduce or stop opioids; switch from CPAP to BiPAP with backup rate (AVAPS) when necessary. Complex central apnea syndrome — central apneas that emerge after CPAP adaptation — is a recognized entity that may require ASV (adaptive servo-ventilation). The medical acupuncturist should order blood gas analysis and an echocardiogram in patients with predominantly central apneas on polysomnography.
Obesity Hypoventilation Syndrome
Obesity hypoventilation syndrome (OHS), formerly called Pickwickian syndrome, is defined by a triad: obesity (BMI above 30 kg/m2), daytime hypercapnia (PaCO2 above 45 mmHg on arterial blood gas while awake), and exclusion of other causes of alveolar hypoventilation. OHS develops when excess thoracic and abdominal adipose tissue compromises respiratory mechanics só severely that CO2 is not adequately cleared even during wakefulness — separating it from simple OSA, where hypercapnia happens only during sleep. It coexists with OSA in 70-90% of cases. Complications include secondary polycythemia, pulmonary hypertension, and cor pulmonale.
Treatment requires noninvasive ventilation with BiPAP or pressure support ventilation (ASV/AVAPS) to correct hypoventilation, plus an intensive weight-loss program — losing 25-30% of body weight can fully resolve the condition. Simple CPAP is not enough in most OHS cases. Acupuncture can be integrated into the treatment plan to support weight loss, modulate appetite, and reduce systemic inflammation, but the priority is to secure adequate ventilation and specialized pulmonology follow-up.
Narcolepsy and Hypersomnia
Narcolepsy type 1 is a central hypersomnia caused by autoimmune-mediated selective loss of hypocretin (orexin)-producing neurons in the lateral hypothalamus. The classic tetrad: irresistible daytime sleepiness (EDS), cataplexy (sudden, reversible loss of muscle tone triggered by positive emotions — laughter, surprise — pathognomonic), sleep paralysis, and hypnagogic/hypnopompic hallucinations. Cataplexy clinically separates narcolepsy type 1 from OSA and from idiopathic hypersomnia. Narcolepsy type 2 occurs without cataplexy, with normal or borderline CSF hypocretin-1, and is a tougher diagnosis. The multiple sleep latency test (MSLT) shows a mean sleep latency below 8 minutes with two or more sleep-onset REM periods.
Idiopathic hypersomnia is another central hypersomnia: excessive daytime sleepiness without cataplexy and an MSLT that does not confirm narcolepsy — a diagnosis of exclusion after OSA, insufficient sleep, and narcolepsy have been ruled out. Pharmacological treatment of narcolepsy includes modafinil, sodium oxybate, and antidepressants for cataplexy. Acupuncture plays an adjunctive role — managing fatigue, improving nocturnal sleep quality, and potentially reducing symptom burden. The medical acupuncturist should promptly refer any patient with suspected narcolepsy or central hypersomnia to a sleep center.
Treatment
The gold-standard treatment for moderate to severe OSA is CPAP (continuous positive airway pressure). Other options include intraoral devices, positional therapy, surgery, and behavioral measures such as weight loss and sleep hygiene.
Behavioral Measures
Weight loss (a 10% drop in body weight can reduce the AHI by 26-32%). Avoid alcohol and sedatives before bed. Quit smoking. Sleep on your side when apnea is position-dependent.
CPAP / BiPAP
Nasal or oronasal CPAP with pressure titrated by polysomnography. It eliminates apneas, normalizes oxygen saturation, and restores sleep architecture. Adherence is the main challenge — 30-50% of patients stop using it.
Intraoral Device
Mandibular advancement device fitted by a sleep dentist. Indicated for mild to moderate OSA or CPAP intolerance. Advances the mandible, increasing the retropharyngeal space.
Surgery and Complementary Therapies
Uvulopalatopharyngoplasty (UPPP), hypoglossal nerve stimulation, and orthognathic surgery in selected cases. Acupuncture as an adjunct to improve pharyngeal muscle tone and sleep quality.
Acupuncture as Treatment
Acupuncture has been investigated as a complementary therapy for OSA, with proposed mechanisms that include possible modulation of the tone of the pharyngeal dilator muscles, modulation of the central chemoreceptor reflex, regulation of the sleep pattern, and reduction of systemic inflammation. The evidence base is still limited and findings should be confirmed in larger studies.
A small Brazilian randomized trial (Freire et al., Sleep Medicine 2007; n=36 with mild to moderate OSA) suggested electroacupuncture reduced the AHI compared with sham acupuncture. The evidence is limited to this single study and does not support its use as primary therapy in moderate or severe OSA. Electroacupuncture at cervical and submental points is being studied as a way to stimulate the pharyngeal muscles, but the long-term clinical effect is not yet established.
Acupuncture does not replace CPAP in moderate to severe OSA. In mild OSA, it can be considered as part of an integrated plan for patients who do not tolerate or refuse CPAP — always with follow-up polysomnography after the treatment cycle and in coordination with the sleep pulmonologist. It can also support CPAP adherence by treating symptoms such as nasal congestion and anxiety.
Prognosis
Untreated OSA is progressive and carries significant cardiovascular consequences. Patients with untreated severe OSA face an increased risk of arterial hypertension, atrial fibrillation, myocardial infarction, stroke, and cardiovascular mortality.
Adequate CPAP treatment normalizes cardiovascular risk in most adherent patients. Substantial weight loss can significantly reduce or even resolve OSA in patients with obesity. Bariatric surgery, when indicated for other reasons, often improves OSA.
Daytime sleepiness, cognitive impairment, and mood changes improve significantly with adequate treatment, usually within the first weeks of regular CPAP use. Sustained adherence is essential to maintain the benefits.
Myths and Facts
Myth vs. Fact
Sleep apnea is just louder snoring
OSA is a disease with serious cardiovascular, metabolic, and cognitive consequences. Snoring is just a symptom — the real damage comes from breathing pauses, hypoxemia, and sleep fragmentation.
Only people with obesity have sleep apnea
Although obesity is the main risk factor, lean people with craniofacial abnormalities (retrognathia, micrognathia, hypertrophied tonsils) can also have significant OSA.
CPAP is uncomfortable and no one can use it
With the right interface and professional follow-up, most patients adapt to CPAP within 2-4 weeks. Modern interfaces are far more comfortable than older ones.
Surgery cures sleep apnea
Uvulopalatopharyngoplasty (UPPP) alone has a success rate of only 40-50%. Surgery requires careful patient selection. Orthognathic surgery delivers better results in selected cases.
When to Seek Help
Suspected sleep apnea should be investigated, especially when habitual snoring is paired with daytime sleepiness, hypertension, or metabolic risk factors.
Frequently Asked Questions about Sleep Apnea
In obstructive apnea (OSA), the airway collapses mechanically but respiratory effort continues — the chest and abdomen move, but no air flows. In central apnea, the brain fails to send the signal to breathe — there is neither effort nor flow. The distinction is made by complete polysomnography, which measures both airflow and respiratory effort.
The AHI (Apnea-Hypopnea Index) counts obstructive events per hour of sleep. AHI 5-14 = mild OSA; AHI 15-29 = moderate OSA; AHI greater than or equal to 30 = severe OSA. Below 5 is normal in adults. Interpret the AHI alongside the minimum oxygen saturation and a daytime sleepiness scale.
CPAP reduces the AHI more than intraoral devices and is the gold standard for moderate to severe OSA. The mandibular advancement device is better tolerated long-term by many patients and works well for mild to moderate OSA. The physician should individualize the choice based on severity, anatomy, tolerance, and patient preference. Both work — if used regularly.
Daytime sleepiness and mood improve in the first week. Blood pressure and cardiovascular markers take weeks to months to drop. For maximum cardiovascular benefit, aim for at least 4 hours per night on more than 70% of nights. Patients who use CPAP for more than 6 hours get the greatest benefits.
Yes. Home polysomnography (type III) is a valid OSA screening option for patients with high clinical probability (STOP-BANG greater than or equal to 5) and no other sleep disorders. It monitors airflow, respiratory effort, oxygen saturation, and body position. It does not assess sleep staging or detect other disorders (periodic limb movements, parasomnias) — complete laboratory polysomnography is required for those.
Always investigate habitual snoring in children. The most common cause is enlarged adenoids and tonsils. Pediatric OSA can cause growth delay, behavioral problems, school difficulties, and, in severe cases, cardiac complications. Pediatric polysomnography uses different criteria than the adult version — any AHI greater than or equal to 1 in a child is abnormal. Tonsillectomy with adenoidectomy is curative in 80-90% of cases.
No, not for moderate to severe OSA. In mild OSA, the trial by Freire et al. (2007) suggests electroacupuncture may reduce the AHI as an adjunct, though the evidence is limited to that small study. For moderate to severe OSA, CPAP remains first-line — acupuncture does not replace it. Follow-up polysomnography after the acupuncture cycle is essential to confirm any objective reduction.
Yes — strongly. OSA is one of the main secondary causes of resistant hypertension (elevated BP despite 3 or more medications). Intermittent hypoxemia and nighttime sympathetic activation chronically raise blood pressure. Treating OSA adequately with CPAP can lower systolic pressure by 2-5 mmHg and, in some cases, allow antihypertensives to be reduced.
AHI greater than or equal to 30 events per hour defines severe OSA. But real severity also depends on the minimum oxygen saturation — desaturations below 80% signal elevated cardiovascular risk regardless of the AHI. The time spent with saturation below 90% (T90) is another important marker of accumulated hypoxemia during sleep.
In mild OSA tied to obesity, substantial weight loss can eliminate apnea entirely. Bariatric surgery cures OSA in 60-80% of patients with morbid obesity. Orthognathic surgery (maxillomandibular advancement) has an 80-90% success rate in selected anatomical cases. For most patients, CPAP is a long-term treatment — effective while used, but not disease-modifying.
Related Reading
Deepen your knowledge with related articles